Advertisement

Index by author

January 01, 1982; Volume 21,Issue 1

A

  1. Aarbakke, J

    1. Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine.
      P M Ueland, J Aarbakke and A Bessesen
      Molecular Pharmacology January 1982, 21 (1) 108-113;

  2. Abita, J P

    1. Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP.
      C Gespach and J P Abita
      Molecular Pharmacology January 1982, 21 (1) 78-85;

  3. Abou-Donia, M B

    1. Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
      K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
      Molecular Pharmacology January 1982, 21 (1) 133-141;

B

  1. Balzarini, J

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

  2. Banks, R B

    1. Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
      P E Hanna, R B Banks and V C Marhevka
      Molecular Pharmacology January 1982, 21 (1) 159-165;

  3. Baum, B J

    1. Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;

  4. Bergstrom, D E

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

  5. Bessesen, A

    1. Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine.
      P M Ueland, J Aarbakke and A Bessesen
      Molecular Pharmacology January 1982, 21 (1) 108-113;

  6. Bickers, D R

    1. Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
      D R Bickers, T Dutta-Choudhury and H Mukhtar
      Molecular Pharmacology January 1982, 21 (1) 239-247;

  7. Borchardt, R T

    1. Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
      R T Borchardt, D Kuonen, J A Huber and A Moorman
      Molecular Pharmacology January 1982, 21 (1) 181-186;

  8. Bourdeaux, M

    1. Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;

  9. Briand, C

    1. Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;

  10. Burch, R M

    1. Inhibition of prostaglandin synthesis antagonizes the colchicine-induced reduction of vasopressin-stimulated water flow in the toad urinary bladder.
      R M Burch and P V Halushka
      Molecular Pharmacology January 1982, 21 (1) 142-149;

  11. Butcher, F R

    1. Rat parotid gland protein kinase activation. Relationship to enzyme secretion.
      T N Spearman and F R Butcher
      Molecular Pharmacology January 1982, 21 (1) 121-127;

  12. Bylund, D B

    1. Regulation of autonomic receptors in rat submandibular gland.
      D B Bylund, J R Martinez and D L Pierce
      Molecular Pharmacology January 1982, 21 (1) 27-35;

C

  1. Cha, S J

    1. Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;

  2. Chabner, B A

    1. Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
      C M Liang, R C Donehower and B A Chabner
      Molecular Pharmacology January 1982, 21 (1) 224-230;

  3. Champion, S

    1. Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
      S Champion and J Mauchamp
      Molecular Pharmacology January 1982, 21 (1) 66-72;
    2. Muscarinic cholinergic receptors on cultured thyroid cells. II. Carbachol-induced desensitization.
      S Champion and J Mauchamp
      Molecular Pharmacology January 1982, 21 (1) 73-77;

  4. Cheng, Y C

    1. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
      B A Domin, Y C Cheng and M T Hakala
      Molecular Pharmacology January 1982, 21 (1) 231-238;

  5. Chiu, T H

    1. Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.
      T H Chiu, D M Dryden and H C Rosenberg
      Molecular Pharmacology January 1982, 21 (1) 57-65;

  6. Coon, M J

    1. Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;

  7. Covey, D F

    1. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
      D F Covey and W F Hood
      Molecular Pharmacology January 1982, 21 (1) 173-180;

  8. Creese, I

    1. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
      M W Hamblin and I Creese
      Molecular Pharmacology January 1982, 21 (1) 44-51;
    2. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
      M W Hamblin and I Creese
      Molecular Pharmacology January 1982, 21 (1) 52-56;

  9. Crooke, S T

    1. The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

D

  1. De Clercq, E

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

  2. De Lean, A

    1. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
      A De Lean, A A Hancock and R J Lefkowitz
      Molecular Pharmacology January 1982, 21 (1) 5-16;

  3. Descamps, J

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

  4. Domin, B A

    1. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
      B A Domin, Y C Cheng and M T Hakala
      Molecular Pharmacology January 1982, 21 (1) 231-238;

  5. Donehower, R C

    1. Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
      C M Liang, R C Donehower and B A Chabner
      Molecular Pharmacology January 1982, 21 (1) 224-230;

  6. Drummond, G S

    1. The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.
      D W Rosenberg, G S Drummond and A Kappas
      Molecular Pharmacology January 1982, 21 (1) 150-158;

  7. Dryden, D M

    1. Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.
      T H Chiu, D M Dryden and H C Rosenberg
      Molecular Pharmacology January 1982, 21 (1) 57-65;

  8. Dutta-Choudhury, T

    1. Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
      D R Bickers, T Dutta-Choudhury and H Mukhtar
      Molecular Pharmacology January 1982, 21 (1) 239-247;

  9. DuVernay, V H

    1. The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

E

  1. Eling, T E

    1. Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
      K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
      Molecular Pharmacology January 1982, 21 (1) 133-141;

  2. Engelborghs, Y

    1. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;

  3. Eubanks, D

    1. The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

F

  1. Ferraiolo, B L

    1. Subunit selectivity in the monooxygenase-like activity of tetrameric hemoglobin.
      B L Ferraiolo and J J Mieyal
      Molecular Pharmacology January 1982, 21 (1) 1-4;

  2. Filburn, C R

    1. Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;

  3. Francis, P R

    1. Biochemical and cell cycle perturbations in methotrexate-treated cells.
      I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
      Molecular Pharmacology January 1982, 21 (1) 204-210;

G

  1. Gelboin, H V

    1. Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;

  2. Gespach, C

    1. Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP.
      C Gespach and J P Abita
      Molecular Pharmacology January 1982, 21 (1) 78-85;

  3. Gilli, R

    1. Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;

  4. Goulian, M

    1. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
      H A Ingraham, B Y Tseng and M Goulian
      Molecular Pharmacology January 1982, 21 (1) 211-216;

H

  1. Hakala, M T

    1. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
      B A Domin, Y C Cheng and M T Hakala
      Molecular Pharmacology January 1982, 21 (1) 231-238;

  2. Halpert, J

    1. Further studies of the suicide inactivation of purified rat liver cytochrome P-450 by chloramphenicol.
      J Halpert
      Molecular Pharmacology January 1982, 21 (1) 166-172;

  3. Halushka, P V

    1. Inhibition of prostaglandin synthesis antagonizes the colchicine-induced reduction of vasopressin-stimulated water flow in the toad urinary bladder.
      R M Burch and P V Halushka
      Molecular Pharmacology January 1982, 21 (1) 142-149;

  4. Hamblin, M W

    1. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
      M W Hamblin and I Creese
      Molecular Pharmacology January 1982, 21 (1) 44-51;
    2. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
      M W Hamblin and I Creese
      Molecular Pharmacology January 1982, 21 (1) 52-56;

  5. Hancock, A A

    1. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
      A De Lean, A A Hancock and R J Lefkowitz
      Molecular Pharmacology January 1982, 21 (1) 5-16;

  6. Hanna, P E

    1. Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
      P E Hanna, R B Banks and V C Marhevka
      Molecular Pharmacology January 1982, 21 (1) 159-165;

  7. Haubrich, D R

    1. The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
      D R Haubrich and A B Pflueger
      Molecular Pharmacology January 1982, 21 (1) 114-120;

  8. Hoebeke, J

    1. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;

  9. Hood, W F

    1. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
      D F Covey and W F Hood
      Molecular Pharmacology January 1982, 21 (1) 173-180;

  10. Hopfinger, A J

    1. Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
      A J Hopfinger and R Potenzone
      Molecular Pharmacology January 1982, 21 (1) 187-195;

  11. Huang, G F

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

  12. Huber, J A

    1. Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
      R T Borchardt, D Kuonen, J A Huber and A Moorman
      Molecular Pharmacology January 1982, 21 (1) 181-186;

I

  1. Ingraham, H A

    1. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
      H A Ingraham, B Y Tseng and M Goulian
      Molecular Pharmacology January 1982, 21 (1) 211-216;

  2. Insel, P A

    1. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
      J S Karliner, H J Motulsky and P A Insel
      Molecular Pharmacology January 1982, 21 (1) 36-43;

  3. Ito, H

    1. Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;

J

  1. Jones, A S

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

K

  1. Kahn, D J

    1. Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.
      D J Kahn, J C Mitrius and D C U'Prichard
      Molecular Pharmacology January 1982, 21 (1) 17-26;

  2. Kappas, A

    1. The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.
      D W Rosenberg, G S Drummond and A Kappas
      Molecular Pharmacology January 1982, 21 (1) 150-158;

  3. Karliner, J S

    1. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
      J S Karliner, H J Motulsky and P A Insel
      Molecular Pharmacology January 1982, 21 (1) 36-43;

  4. Kuonen, D

    1. Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
      R T Borchardt, D Kuonen, J A Huber and A Moorman
      Molecular Pharmacology January 1982, 21 (1) 181-186;

L

  1. Lasker, J M

    1. Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
      K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
      Molecular Pharmacology January 1982, 21 (1) 133-141;

  2. Lefkowitz, R J

    1. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
      A De Lean, A A Hancock and R J Lefkowitz
      Molecular Pharmacology January 1982, 21 (1) 5-16;

  3. Liang, C M

    1. Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
      C M Liang, R C Donehower and B A Chabner
      Molecular Pharmacology January 1982, 21 (1) 224-230;

M

  1. Maes, V

    1. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;

  2. Maras, Y

    1. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;

  3. Marhevka, V C

    1. Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
      P E Hanna, R B Banks and V C Marhevka
      Molecular Pharmacology January 1982, 21 (1) 159-165;

  4. Martinez, J R

    1. Regulation of autonomic receptors in rat submandibular gland.
      D B Bylund, J R Martinez and D L Pierce
      Molecular Pharmacology January 1982, 21 (1) 27-35;

  5. Mauchamp, J

    1. Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
      S Champion and J Mauchamp
      Molecular Pharmacology January 1982, 21 (1) 66-72;
    2. Muscarinic cholinergic receptors on cultured thyroid cells. II. Carbachol-induced desensitization.
      S Champion and J Mauchamp
      Molecular Pharmacology January 1982, 21 (1) 73-77;

  6. Mieyal, J J

    1. Subunit selectivity in the monooxygenase-like activity of tetrameric hemoglobin.
      B L Ferraiolo and J J Mieyal
      Molecular Pharmacology January 1982, 21 (1) 1-4;

  7. Miller, H

    1. Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;

  8. Mitrius, J C

    1. Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.
      D J Kahn, J C Mitrius and D C U'Prichard
      Molecular Pharmacology January 1982, 21 (1) 17-26;

  9. Moorman, A

    1. Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
      R T Borchardt, D Kuonen, J A Huber and A Moorman
      Molecular Pharmacology January 1982, 21 (1) 181-186;

  10. Motulsky, H J

    1. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
      J S Karliner, H J Motulsky and P A Insel
      Molecular Pharmacology January 1982, 21 (1) 36-43;

  11. Mukhtar, H

    1. Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
      D R Bickers, T Dutta-Choudhury and H Mukhtar
      Molecular Pharmacology January 1982, 21 (1) 239-247;

P

  1. Park, S S

    1. Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;

  2. Perales, R

    1. The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

  3. Persson, A V

    1. Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;

  4. Peyrot, V

    1. Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;

  5. Pflueger, A B

    1. The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
      D R Haubrich and A B Pflueger
      Molecular Pharmacology January 1982, 21 (1) 114-120;

  6. Pierce, D L

    1. Regulation of autonomic receptors in rat submandibular gland.
      D B Bylund, J R Martinez and D L Pierce
      Molecular Pharmacology January 1982, 21 (1) 27-35;

  7. Potenzone, R

    1. Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
      A J Hopfinger and R Potenzone
      Molecular Pharmacology January 1982, 21 (1) 187-195;

  8. Prestayko, A W

    1. The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

R

  1. Rosenberg, D W

    1. The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.
      D W Rosenberg, G S Drummond and A Kappas
      Molecular Pharmacology January 1982, 21 (1) 150-158;

  2. Rosenberg, H C

    1. Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.
      T H Chiu, D M Dryden and H C Rosenberg
      Molecular Pharmacology January 1982, 21 (1) 57-65;

  3. Roth, G S

    1. Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;

S

  1. Sacktor, B

    1. Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;

  2. Sari, J C

    1. Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;

  3. Sarrazin, M

    1. Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;

  4. Sellinger-Barnette, M

    1. Interaction of beta-endorphin and other opioid peptides with calmodulin.
      M Sellinger-Barnette and B Weiss
      Molecular Pharmacology January 1982, 21 (1) 86-91;

  5. Serafinowski, P

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

  6. Sivarajah, K

    1. Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
      K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
      Molecular Pharmacology January 1982, 21 (1) 133-141;

  7. Slowiaczek, P

    1. Biochemical and cell cycle perturbations in methotrexate-treated cells.
      I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
      Molecular Pharmacology January 1982, 21 (1) 204-210;

  8. Spearman, T N

    1. Rat parotid gland protein kinase activation. Relationship to enzyme secretion.
      T N Spearman and F R Butcher
      Molecular Pharmacology January 1982, 21 (1) 121-127;

T

  1. Tattersall, M H

    1. Biochemical and cell cycle perturbations in methotrexate-treated cells.
      I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
      Molecular Pharmacology January 1982, 21 (1) 204-210;

  2. Taylor, I W

    1. Biochemical and cell cycle perturbations in methotrexate-treated cells.
      I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
      Molecular Pharmacology January 1982, 21 (1) 204-210;

  3. Torrence, P F

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

  4. Tseng, B Y

    1. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
      H A Ingraham, B Y Tseng and M Goulian
      Molecular Pharmacology January 1982, 21 (1) 211-216;

U

  1. U'Prichard, D C

    1. Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.
      D J Kahn, J C Mitrius and D C U'Prichard
      Molecular Pharmacology January 1982, 21 (1) 17-26;

  2. Uchida, T

    1. Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;

  3. Ueland, P M

    1. Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine.
      P M Ueland, J Aarbakke and A Bessesen
      Molecular Pharmacology January 1982, 21 (1) 108-113;

V

  1. Vercruysse, A

    1. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;

  2. Verhelst, G

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

W

  1. Walker, R T

    1. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

  2. Weiss, B

    1. Interaction of beta-endorphin and other opioid peptides with calmodulin.
      M Sellinger-Barnette and B Weiss
      Molecular Pharmacology January 1982, 21 (1) 86-91;
Back to top

In this issue